Case Summary (G.R. No. 209271)
Key Dates and Applicable Law
- Decision date of the Supreme Court: 8 December 2015 (1987 Constitution governs).
- Court of Appeals decision: 17 May 2013; CA resolution denying reconsideration: 20 September 2013.
- Administrative and international instruments in the record: 1987 Philippine Constitution (esp. rights to health and balanced ecology); PD No. 1151 and PD No. 1586 / the Philippine EIS System; DA Administrative Order No. 08‑2002 (DAO 08‑2002); Executive Order No. 430 (NCBP, 1990); Executive Order No. 514 (National Biosafety Framework, NBF, 2006); Cartagena Protocol on Biosafety and CBD; Rules of Procedure for Environmental Cases (A.M. No. 09‑6‑8‑SC), Rule 20 (precautionary principle); writ of kalikasan and writ of continuing mandamus procedures.
Factual and regulatory background
Biotechnology overview in the record: modern biotechnology defined and its agricultural applications summarized; the Philippines established a biosafety regulatory architecture beginning with EO No. 430 (NCBP) and national biosafety guidelines in 1991 (revised 1998); DAO 08‑2002 was promulgated by DA to regulate importation and release of plant products derived from modern biotechnology (assigned field testing regulation primarily to DA‑BPI); EO No. 514 established the National Biosafety Framework (NBF) in 2006, prescribed coordination among agencies and required precaution and public participation; the Cartagena Protocol was signed and ratified by the Philippines and invoked as normative background; the PEISS (PD 1151/PD 1586) governs Environmental Impact Statement (EIS) requirements and Environmental Compliance Certificates (ECCs). UPLB and partners entered a Memorandum of Undertaking (24 Sept. 2010) and obtained BPI biosafety permits (March and June 2010) to conduct multi‑locational field testing of Bt talong after contained experiments; respondents alleged insufficient public consultation, absence of EIS/ECC, inadequacy of risk assessment and peer‑reviewed safety data, and potential for irreversible environmental and health harms (contamination, non‑target effects, resistance, socio‑economic impacts).
Reliefs sought by respondents and procedural posture
Respondents sought: issuance of TEPO enjoining processing/field testing/registration and ordering uprooting of planted Bt talong; writ of continuing mandamus ordering (inter alia) compliance with PEIS/EIS, submission of independent risk assessments and proof of public consultations, and reforms to biosafety framework; writ of kalikasan directing returns and accountability; cancellation of non‑compliant field experiments; recommendation of curative legislation. The Supreme Court issued the writ of kalikasan (2 May 2012) and referred the returns to the Court of Appeals for hearing, which the CA adjudicated and in part granted (permanent cessation of Bt talong field trials). Petitioner agencies and proponents brought consolidated petitions to the Supreme Court seeking reversal.
Court of Appeals proceedings and reasoning (as recited in the record)
- CA accepted petitioners’ returns for hearing, conducted a concurrent expert‑witness “hot‑tub” hearing where experts for both sides testified together.
- CA concluded that DA/DOST regulations (DAO 08‑2002 and related issuances) were insufficient to guarantee environmental and health safety; observed scientific uncertainty, cited expert testimony urging maximum precaution and the possibility of irreversible ecological effects; applied Rule 20 (precautionary principle) of the environmental rules; and granted the writ of kalikasan, permanently enjoining field testing and directing environmental protection measures. CA denied motions for reconsideration and rejected the contention that the CA decision violated academic freedom because it enjoined only field trials (procedural component) not all research.
Main arguments of petitioners (as presented in the record)
- ISAAA, proponents and some intervenors argued: case moot or academic; issues raised political and non‑justiciable; respondents failed to exhaust administrative remedies and primary jurisdiction lies with regulatory agencies (BPI/DA); evidence did not demonstrate actual or imminent environmental harm; the precautionary principle was misapplied; reliance on contested literature (e.g., Seralini) was improper; findings of the BPI and scientific reviewers should be accorded respect/finality; field testing is not equivalent to commercialization; academic freedom of UP/UPLB was infringed. Public agencies contended they followed DAO 08‑2002, implemented risk assessment (IBC, STRP reviews), and engaged in public information and consultations as required; EMB claimed resource and competence limitations in EIS classification responsibilities but acknowledged role under EO 514.
Respondents’ principal contentions (as presented in the record)
Respondents argued: substantial scientific uncertainty and peer‑reviewed studies/compilations raised plausible risks; field trials lacked robust independent risk assessment, EIS/ECC and meaningful public consultation; documented instances of contamination and global experiences illustrated real contamination risks; Bt talong field trials threatened biodiversity, non‑target organisms and future farmers’ seed sovereignty; and DAO 08‑2002 and related practices failed to implement NBF principles (transparency, broad public participation, precaution).
Issues the Supreme Court framed for decision
(1) Legal standing of respondents; (2) Mootness of the controversy; (3) Applicability of doctrines of primary jurisdiction and exhaustion of administrative remedies; (4) Whether the PEIS/EIS and ECC requirements apply to GMO field testing; (5) Whether record evidence showed damage or threat of damage to human health/environment in two or more provinces; (6) Whether public respondents (EMB/BPI/FPA) neglected or unlawfully omitted duties in permit processing and evaluation; and (7) Application of the precautionary principle.
Supreme Court holding — disposition
- The consolidated petitions were DENIED.
- The Court MODIFIED the CA decision and ordered: (1) the conduct of the assailed Bt talong field testing is PERMANENTLY ENJOINED; (2) Department of Agriculture Administrative Order No. 08, series of 2002 (DAO 08‑2002) is declared NULL AND VOID; and (3) any application for contained use, field testing, propagation, commercialization, and importation of genetically modified organisms is TEMPORARILY ENJOINED until a new administrative order is promulgated in accordance with law. No costs were imposed.
Standing and justiciability reasoning
- The Court applied the liberalized doctrine of standing developed in Oposa and embodied in the Rules of Procedure for Environmental Cases: citizens and civic organizations may file citizen suits to protect the people’s right to a balanced and healthful ecology; respondents had sufficient standing.
- Mootness: although the specific permits had expired and field trials were reported terminated, the Court found two exceptions to mootness justified consideration: (a) the matter is capable of repetition yet evading review (proponents expected to proceed to commercial propagation phases and future BPI permits could be sought), and (b) paramount public interest in human and environmental health. These exceptions allowed the Court to decide despite factual developments.
Primary jurisdiction / exhaustion of administrative remedies reasoning
- The Court explained the doctrines: ordinarily courts defer to administrative bodies and require exhaustion, but exceptions exist (e.g., lack of adequate, speedy remedy; where strong public interest is present).
- DA/BPI procedures under DAO 08‑2002 were found not to provide a speedy, adequate remedy for the public stakeholders seeking broad biosafety, environmental and public policy determinations; DAO 08‑2002 addressed procedural requirements for applicants rather than furnishing stakeholders a meaningful adjudicative remedy. Consequently, respondents were justified in invoking judicial remedies under the environmental rules; exhaustion and primary jurisdiction doctrines did not bar judicial intervention.
EIS/PEISS and National Biosafety Framework (NBF) reasoning
- The Court held that DAO 08‑2002 and implementing practice did not satisfactorily operationalize the NBF’s principles, particularly as to public participation, transparency and the precautionary approach. EO 514 expressly contemplated that concerned agencies should determine the applicability of the Philippine Environmental Impact Statement System (PEISS) to biosafety decisions and issue joint guidelines. The NBF also requires public participation far more robust than the posting/30‑day comment mechanism in DAO 08‑2002.
- The Court found that petitioners (particularly DENR‑EMB) failed to fulfill mandates under EO 514 to ensure environmental assessments are done and impacts identified in biosafety decisions; EMB’s testimony indicated resource/competence limitations and a lack of proactive application of PEISS to GM field trials. Given the NBF’s requirements, the Court concluded DAO 08‑2002 was insufficient and declared it void.
Evidence, expert testimony, and application of the precautionary principle
- The record showed divergent expert opinions and conflicting scientific literature; the CA’s “hot‑tub” concurrent expert testimony produced no consensus regarding safety or harm from Bt talong. The Seralini study was discussed extensively in the proceedings and in the record (its retraction and later republication were noted). The Court observed the international debate and the absence of scientifically decisive findings that would eliminate plausible risk.
- Under Rule 20 of the environmental rules and international instruments (Cartagena Protocol, Rio Declaration), the Court applied the precautionary principle because the record exhibited: (a) significant scientific uncertainty as to causal links; (b) scientifically plausible scenarios of serious or
Case Syllabus (G.R. No. 209271)
Caption and Parties
- Case consists of consolidated petitions (G.R. Nos. 209271, 209276, 209301, 209430) involving multiple petitioners and common respondents concerning field trials of genetically modified eggplant (Bt talong).
- Principal petitioners include: International Service for the Acquisition of Agri-Biotech Applications, Inc. (ISAAA); Crop Life Philippines, Inc. (intervenor); Department of Environment and Natural Resources – Environmental Management Bureau (EMB); Bureau of Plant Industry (BPI); Fertilizer and Pesticide Authority (FPA); University of the Philippines Los BaAos Foundation, Inc. (UPLBFI); UP Los BaAos (UPLB); and University of the Philippines (UP).
- Principal respondents/petitioners in the underlying petition: Greenpeace Southeast Asia (Philippines), MASIPAG (Magsasaka at Siyentipiko sa Pagpapaunlad ng Agrikultura), a list of individual scientists, public officials and citizens (named respondents), suing on behalf of present and future generations invoking constitutional rights to health and a balanced ecology.
- Parties’ institutional descriptions drawn from the record:
- Greenpeace (Philippines): non-governmental environmental organization, Philippine branch of Greenpeace Southeast Asia.
- ISAAA: international non-profit promoting agricultural biotechnology, partially funded by USAID.
- MASIPAG: coalition of local farmers, scientists and NGOs advocating farmers’ control of biodiversity and sustainable management.
- UPLB: autonomous constituent of UP, center of biotechnology education and research in Southeast Asia.
- UPLBFI: private corporation assisting UPLB in utilizing expertise and assets for revenue generation and project support.
- UP: national university under RA 9500, mandated to serve as research university and undertake basic and applied research.
Procedural Posture and Reliefs Sought
- Respondents (Greenpeace et al.) filed a petition for writ of kalikasan and writ of continuing mandamus with prayer for Temporary Environmental Protection Order (TEPO) on April 26, 2012 seeking:
- Immediate TEPO enjoining BPI/FPA/DA from processing field testing or registering Bt talong and stopping all pending field tests and ordering uprooting of planted Bt talong.
- Writ of continuing mandamus directing: submission to the PEIS/EIS system; independent and comprehensive risk assessments, field test reports and compliance documents; certifications of public consultation and consent of LGUs; drafting of amended National Biosafety Framework (NBF) and DA AO No. 08 to incorporate independent transparent socio-economic and scientific risk assessment procedures; and balanced nationwide public information and social acceptability survey.
- Writ of kalikasan commanding respondents to explain why they should not be sanctioned for violations/threats to laws/principles and to cancel field experiments found to be violating laws and recommend curative legislation.
- Supreme Court initially issued writ of kalikasan on May 2, 2012 ordering verified returns within ten (10) days as per Rule 8, Rule 7 of Rules of Procedure for Environmental Cases.
- Case referred to the Court of Appeals (CA) for receipt of returns, hearing and judgment; CA rendered Decision on May 17, 2013 granting the petition and permanently enjoined Bt talong field trials; CA Resolution denying reconsideration dated September 20, 2013.
- Petitions for certiorari filed in the Supreme Court seeking reversal of CA Decision and Resolution and other reliefs; Decision rendered by the Supreme Court on December 8, 2015 modifying CA ruling, permanently enjoining field testing, declaring DA AO No. 08 (2002) null and void, and temporarily enjoining any application for contained use, field testing, propagation and commercialization, and importation of GMOs until a new administrative order promulgated.
Factual Background — Biotechnology and Regulatory Timeline
- Biotechnology defined and described: multidisciplinary techniques using living organisms or their products to alter organisms, develop products and improve plants or animals, with applications across agriculture, livestock, industry and pharmaceuticals.
- Philippine institutional/regulatory milestones:
- 1979: Establishment of BIOTECH at UPLB (National Institute for Applied Microbiology and Biotechnology).
- 1990: EO No. 430 creating the National Committee on Biosafety of the Philippines (NCBP); 1991 NCBP Philippine Biosafety Guidelines (contained use).
- 1998: Guidelines on Planned Release of GMOs and Potentially Harmful Exotic Species.
- 1993: Convention on Biological Diversity enters into force (global context).
- 2000: Cartagena Protocol on Biosafety agreed; Philippines signed on May 24, 2000; entered into force September 11, 2003; Senate concurred via Senate Resolution No. 92 (2010) to ratification.
- 2001: Presidential policy statement promoting safe and responsible use of modern biotechnology.
- 2002: DA Administrative Order No. 08 (DAO 08-2002) governing importation and release into the environment of plants/plant products derived from modern biotechnology (covers field testing and propagation; contained use remained under NCBP).
- 2006: EO No. 514 establishing the National Biosafety Framework (NBF), prescribing guidelines and strengthening NCBP; EO 514 declares NBF applicable to all biosafety policy and decisions and makes precaution part of decision-making; provides funding provisions and duties for DOST, DENR, DA, DOH; specifies that DAO 08-2002 remains in force unless amended.
Project and Field Trials at Issue (Bt talong project)
- Memorandum of Undertaking dated September 24, 2010 between UPLBFI, ISAAA and UP Mindanao Foundation, Inc. (UPMFI) for collaborative R&D project on eggplant resistant to fruit and shoot borer; other partners: UPLB Institute of Plant Breeding, MAHYCO (India), Cornell, ABSPII (USAID).
- Field Trial Proposal described pest-resistant crop as "bioengineered eggplant" incorporating Bacillus thuringiensis (Bt) crystal toxin genes to produce Cry1Ac protein toxic to lepidopteran larvae, notably fruit and shoot borer (FSB).
- Contained experiment commenced in 2007, officially completed March 3, 2009; NCBP issued Certificate of Completion of Contained Experiment stating compliance and no untoward incidents.
- BPI issued Biosafety Permits to UPLB on March 16, 2010 and June 28, 2010; field testing conducted at multi-locations: Kabacan (North Cotabato); Sta. Maria (Pangasinan); Pili (Camarines Sur); Bago Oshiro (Davao City); Bay (Laguna).
- Reported local government reactions and community complaints in several sites (Bay, Laguna; Baybay, Leyte; Davao City; Sta. Barbara, Iloilo) raising concerns about transparency, public consultation, risk assessment, contamination and compliance with local participation rules.
Petitioners’ (Proponents / Government Agencies) Principal Contentions
- ISAAA, UPLB/UPLBFI, EMB/BPI/FPA, UPMFI and intervenors argued:
- Field tests complied with applicable environmental laws, biosafety rules and required public consultations under DAO 08-2002 and NBF; Bt talong field trials do not cause environmental damage or prejudice the life/health/property of inhabitants of two or more provinces or cities.
- Bt talong field trials are not covered by PEIS/EIS law; environmental impact statement requirement inapplicable to controlled field trials.
- NBF and DAO 08-2002 provide adequate risk assessment and safeguards; BPI conducted risk assessments using Institutional Biosafety Committee (IBC) and Scientific Technical Review Panel (STRP) reports and found applications sufficient.
- Petitioner-proponents contended the CA misapplied the precautionary principle despite respondents’ failure to present admissible scientific evidence; relied on contested studies (e.g., Seralini) which were not admitted or were controversial.
- Petitioners asserted exhaustion of administrative remedies and primary jurisdiction of regulatory agencies (BPI, DA) as a threshold and argued the CA intruded on political questions, policy-making and scientific determinations deserving deference to specialized agencies.
- ISAAA argued some allegations irrelevant at field trial stage since field trial produce not for consumption and destroyed per permit requirements; cited long history of safe use of Bt crops and Bt microbial pesticides; requested dismissal for mootness or lack of justiciability in some respects.
Respondents’ (Greenpeace, MASIPAG, individuals) Principal Contentions
- Allegations of procedural and substantive omissions and risks:
- Failure to secure Environmental Compliance Certificate (ECC) under PD No. 1151 prior to project implementation; assertion DAO 08-2002 cannot substitute for PEIS.
- Bt talong as regulated article poses presumed harm; lack of independent, peer-reviewed safety studies for human consumption and environment; reliance on studies (e.g., Seralini) and local scientific attestations alleging harm.
- Specific asserted environmental/health risks: toxicity to non-target species (e.g., monarch butterfly concerns), increased mortality in beneficial insects via trophic transfer, secondary pest outbreaks (China Bt cotton data), selection for Bt-resistant pests increasing pesticide use, pollen-mediated contamination (argument that BPI 200 m pollen-trap insufficient given pollinator flight distances and eggplant insect-pollination rates).
- Claim of inadequate public consultation and noncompliance with Sections 26 & 27 Local Government Code; evidence of lack of awareness in some host communities.
- Invocation of the precautionary principle because scientific evidence is conflicting, uncertain or insufficient, and preliminary evaluation indicates reasonable grounds for concern including possibility of irreversible damage.
- Requested TEPO, writs of kalikasan and continuing mandamus; sought validation of people’s right to health and a balanced ecology.
CA Proceedings, Evidence Mode and Decision
- CA conducted preliminary conference (Sept 12, 2012) and resolved in October 12, 2012:
- Greenpeace et al. possess legal